Physician profile
Daniel Bradke
NPI 1528420320
$1,633.16
in general payments reported to CMS, 2019-2025
23 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.28 · 2021: $301 · 2022: $333 · 2023: $400 · 2024: $348 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $972.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $972.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.64 | 2021-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $231.18 | 2021-2025 | Acessa Provu System, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $189.59 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $150.46 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $107.80 | 2024-2025 | Veozah |
| Organon LLC | $105.52 | 2021-2025 | Nexplanon |
| Mayne Pharma Commercial LLC | $92.39 | 2023-2025 | |
| Exact Sciences Corporation | $72.76 | 2023-2025 | Cologuard Collection Kit |
| Coopersurgical, INC. | $65.38 | 2020-2025 | Paragard T 380a |
| Aspira Women'S Health INC | $60.56 | 2022-2024 | Ova1 |
| Shield Therapeutics INC | $48.51 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $41.87 | 2021 | |
| Evofem Biosciences, INC. | $38.77 | 2021 | |
| Boston Scientific Corporation | $28.50 | 2023 | Watchman Flx |
| Mylan Pharmaceuticals INC. | $25.40 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $24.15 | 2024 | |
| Convatec INC. | $21.11 | 2022 | |
| Agile Therapeutics, INC. | $17.02 | 2023 | Twirla |
| Intuitive Surgical, INC. | $16.57 | 2024 | |
| Lupin INC. | $14.88 | 2020 | |
| Exeltis, USA INC. | $14.31 | 2021 | |
| Avion Pharmaceuticals | $12.85 | 2022 | |
| Myovant Sciences INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bradke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.